Advertisement

S103. The International Study to Predict Optimized Treatment in Depression (iSPOT-D): Recent Findings and Future Directions

      The International Study to Predict Optimized Treatment in Depression (iSPOT-D) is a randomized clinical looking at biomarkers of antidepressant treatment outcome in outpatients with non-psychotic Major Depressive Disorder. It is the first to take an integrative neuroscience approach to biomarker discovery, looking across the disciplines of structural and functional MRI, EEG, cognitive performance, and genomics, all in the same patients.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Biological Psychiatry
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect